Back to search

United States· US:69945-092_4b00526c-6250-49d7-ba34-459ef89c8f43

Technetium Tc 99m Sestamibi

A medicinal product containing tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate, registered in United States by Curium US LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTechnetium Tc 99m SestamibiATC—REGISTER NO.US:69945-092_4b00526c…PACKS LISTED4CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
Manufacturer
Curium US LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    6994509220
    5 VIAL in 1 CELLO PACK (69945-092-20) / 10 mL in 1 VIAL
  • ndc11
    6994509240
    30 VIAL in 1 CARTON (69945-092-40) / 10 mL in 1 VIAL
  • ndc11
    69945-092-20
  • ndc11
    69945-092-40

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c651b2bf-1fc2-414a-9ebf-67305c4c7342
GET /v1/drugs/c651b2bf-1fc2-414a-9ebf-67305c4c7342?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE",
  "productndc": "69945-092",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA078098",
  "marketing_category": "ANDA"
}

See everything about tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.